| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |